Trial Profile
Otiprio Versus Ciprodex to Reduce Tympanostomy Tube Failure
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary) ; Ciprofloxacin/dexamethasone
- Indications Otitis media; Otorrhoea
- Focus Therapeutic Use
- 12 Sep 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to low use of Otiprio among otolaryngologists.
- 07 May 2018 Planned End Date changed from 1 Jan 2019 to 1 Jun 2019.
- 07 May 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Jun 2019.